Scientific article
Open access

Management of patients with nephrotic syndrome

Published inSchweizerische medizinische Wochenschrift, vol. 139, no. 29-30, p. 416-422
Publication date2009

Nephrotic syndrome is characterised by proteinuria >3.5 g/24h, oedema, hypoalbuminaemia and hyperlipidaemia. Several glomerular diseases, either primary or secondary, may lead to nephrotic syndrome. Investigations for nephrotic syndrome include immunological and infectious evaluations. Renal biopsy is often mandatory, except in diabetes. Depending on aetiology specific treatment, often with immunosuppressive agents, may be implemented. In any cases nonspecific treatment should be started with ACE inhibitors or ARBs. Urinary protein loss leads to several complications: water and sodium retention, hyperlipidaemia, increased risk of thromboembolism and infection, anaemia and alteration of mineral metabolism. Each of these complications must be identified.

  • Anemia/etiology
  • Angiotensin II Type 1 Receptor Blockers/*therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
  • Dyslipidemias/etiology
  • Edema/etiology
  • Humans
  • Hypertension/drug therapy/etiology
  • Nephrotic Syndrome/complications/diagnosis/*drug therapy
  • Thromboembolism/etiology
Citation (ISO format)
DE SEIGNEUX, S., MARTIN, Pierre-Yves. Management of patients with nephrotic syndrome. In: Schweizerische medizinische Wochenschrift, 2009, vol. 139, n° 29-30, p. 416–422. doi: 10.4414/smw.2009.12477
Main files (1)
ISSN of the journal0036-7672

Technical informations

Creation04/23/2012 10:26:45 AM
First validation04/23/2012 10:26:45 AM
Update time03/14/2023 5:23:00 PM
Status update03/14/2023 5:23:00 PM
Last indexation02/12/2024 7:53:43 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack